SCHEMBL4603427

SCHEMBL4603427

Cc1n[nH]c(-c2ccc(C(=O)NS(=O)(=O)CC3CC(=O)N(c4ccc(N5CCCCC5=O)cc4)C3)s2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 10/20 0.39
F2 P00734 1/20 0.36
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
GRK6 P43250 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
PKM P14618 2/20 0.34
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
PRMT5 O14744 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5640790 0.88 F10 (0.49) F10F2NPC1RAB9ASMN1; SMN2
SCHEMBL4602805 0.77 F10 (0.38) F10F2KDM4EALDH1A1PKM
SCHEMBL4605200 0.76 PRMT5 (0.39) F10F2KDM4EALDH1A1PKM
SCHEMBL4604856 0.74 CHRNA7 (0.42) F10F2RAB9ALMNAPRMT5
SCHEMBL4594596 0.73 LMNA (0.39) F10NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL4586271 0.73 F10 (0.51) F10F2
SCHEMBL4287825 0.70 F10 (0.52) F10F2
SCHEMBL5638163 0.69 F10 (0.51) F10F2LMNA
SCHEMBL4593238 0.69 KLKB1 (0.42) F10KDM4EALDH1A1LMNAPRMT5
SCHEMBL4603648 0.69 LMNA (0.41) F10NPC1RAB9ALMNAPRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667647-A4 MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-10-22 EP disclosed
EP-1667647-A2 MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2006-06-14 EP disclosed
WO-2005032468-A2 MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-04-14 WO disclosed